美国炎症性肠病患者社会风险的患病率及其影响:全国性估计
基于美国2023年全国健康访谈调查,纳入572例炎症性肠病成人患者,评估6个领域社会风险。64%存在至少1个领域社会风险,严重社会风险在少数族裔中患病率更高;校正收入与保险后,严重社会风险与计划外医疗使用(OR 3.5)及费用相关药物不依从(OR 11.8)相关。
要点
- 64%的炎症性肠病成人存在至少1个领域的社会风险,歧视最常见(41%)。
- 严重社会风险患病率:非西班牙裔黑人37% vs 西班牙裔28% vs 非西班牙裔白人12%。
- 严重社会风险与计划外医疗使用(OR 3.5)及费用相关药物不依从(OR 11.8)相关。
核心结论
- 社会风险在炎症性肠病成人中普遍存在,并对医疗使用和药物不依从产生负面影响。
- 作者认为,常规识别和处理炎症性肠病患者的社会风险应成为标准临床诊疗的一部分。
研究设计与样本
- 基于美国2023年全国健康访谈调查的横断面研究,纳入572例炎症性肠病成人患者。
- 评估6个领域社会风险(食品不安全、经济困难、住房不稳定、交通需求、教育与就业、歧视)。
- 分析社会风险负担(0、1、2、≥3个领域)与计划外医疗使用及药物不依从的关联,并校正年龄、性别、种族/族裔、保险、收入和合并症。
主要发现
- 572例患者平均年龄56岁,女性占57%,非西班牙裔白人占81%,西班牙裔占12.9%。
- 64%(95%CI 59%-69%)经历至少1个领域社会风险:食品不安全22%、经济困难28%、住房不稳定14%、交通需求9%、教育与就业9%、歧视41%。
- 严重社会风险患病率:非西班牙裔黑人37% vs 西班牙裔28% vs 非西班牙裔白人12%。
- 校正收入和保险后,严重社会风险 vs 无社会风险与计划外医疗使用相关(OR 3.5;95%CI 1.2-10.2)。
- 校正收入和保险后,严重社会风险 vs 无社会风险与费用相关药物不依从相关(OR 11.8;95%CI 2.7-52.1)。
关键数值与推荐
- 社会风险负担分为:0个领域(无)、1个领域(轻度)、2个领域(中度)、≥3个领域(严重)。
- 社会风险领域包括:食品不安全、经济困难、住房不稳定、交通需求、教育与就业、歧视。
- 计划外医疗使用定义为急诊科就诊和/或住院。
临床怎么用
- 作者认为,常规识别和处理炎症性肠病患者的社会风险应成为标准临床诊疗的一部分。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Social risks are individual-level factors associated with adverse health outcomes. We determined the prevalence and impact of social risks on healthcare use among patients with inflammatory bowel diseases (IBDs) in the United States. METHODS: In the U.S. National Health Interview Survey 2023, we estimated social risks across 6 domains (food insecurity, financial hardship, housing instability, transportation needs, education and employment, discrimination) in adults with IBD. We evaluated the association between burden of social risk (0 of 6 domains [none], 1 of 6 domains [mild], 2 of 6 domains [moderate], and ≥3 of 6 domains [severe]), unplanned healthcare utilization (emergency department and/or hospitalization), and medication nonadherence, accounting for differences in age, sex, race/ethnicity, insurance, income, and comorbidities. RESULTS: Of 572 people included in the survey (mean age 56 years; 57% female; 81% non-Hispanic White [NHW], 12.9% Hispanic), 64% (95% confidence interval [CI], 59%-69%) experienced social risk across 1 or more domains (food insecurity, 22%; financial hardship, 28%; housing instability, 14%; transportation needs, 9%; education and employment, 9%; discrimination, 41%). Prevalence of severe social risk was higher in racial and ethnic minority groups (non-Hispanic Black vs Hispanic vs NHW: 37% vs 28% vs 12%). A higher burden of social risk was associated with higher risk of unplanned healthcare utilization (severe vs none: odds ratio, 3.5; 95% CI, 1.2-10.2) and cost-related medication nonadherence (OR, 11.8; 95% CI, 2.7-52.1), after accounting for income and insurance status. CONCLUSIONS: Social risks are prevalent in adults with IBD and negatively impact healthcare utilization and medication nonadherence. Efforts to routinely identify and address social risks in patients with IBD should be part of standard clinical care.
引用
- Kim E, Qi Y, Banegas MP, et al. Prevalence and Impact of Social Risk in Patients With Inflammatory Bowel Diseases: National Estimates From the United States. Clin Gastroenterol Hepatol. 2025. PMID: 40473090. doi:10.1016/j.cgh.2025.03.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。